Kushim Tablets recall
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
Why was Kushim Tablets recalled?
Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: H003
- Product
- Kushim Tablets (Gushim) 45-count packages, Label in foreign language
- Recalling firm
- B AND A TRADING CORPORATION
- Quantity
- 40 packages
- Distribution
- NY & NJ only
- Recall date
- February 19, 2020
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)